Effects of hypothalamic periventricular lesions on pulsatile growth hormone secretion
- PMID: 2865689
- DOI: 10.1159/000124202
Effects of hypothalamic periventricular lesions on pulsatile growth hormone secretion
Abstract
The purpose of this study was to determine the effects of destroying somatostatin (SRIF) neurons of the periventricular (PV) nucleus of the hypothalamus on the pulsatile pattern of growth hormone (GH) secretion in female rats. At 6-10 days after placement of PV lesions, blood samples collected every 15 min for 3-4 h showed an elevation in baseline GH levels and an increase in the amplitude of GH secretory peaks; the frequency of pulses was not affected. These changes were associated with an increase in mean integrated plasma GH levels. The alterations appeared transient because nonstress plasma GH levels were normal in two blood samples collected between 6 and 17 weeks after lesion placement and at autopsy at 17 weeks. Stress-induced suppression of GH secretion was also unaffected by the PV lesions. These lesions severely compromised the SRIF system that projects to the median eminence because the median eminence content of SRIF was approximately 85% depleted in the lesioned group. These results confirm that the hypothalamic PV nucleus is essential for maintaining most of the SRIF in the median eminence and demonstrate that damage to the PV nucleus causes transient alterations in the pulsatile pattern of GH secretion. However, the PV nucleus does not appear to play a major role in driving pulsatile GH secretion.
Similar articles
-
Long term elevations in plasma thyrotropin, but not growth hormone, concentrations associated with lesion-induced depletion of median eminence somatostatin.Endocrinology. 1983 Feb;112(2):659-64. doi: 10.1210/endo-112-2-659. Endocrinology. 1983. PMID: 6129135
-
Somatostatin content of the median eminence in female rats with lesion-induced disruption of the inhibitory control of growth hormone secretion.Endocrinology. 1978 Sep;103(3):817-25. doi: 10.1210/endo-103-3-817. Endocrinology. 1978. PMID: 744118
-
Inhibitory effect of hypothalamic medial preoptic area somatostatin on growth hormone-releasing factor in the rat.Endocrinology. 1988 Aug;123(2):1103-9. doi: 10.1210/endo-123-2-1103. Endocrinology. 1988. PMID: 2899498
-
[A hypothalamic hormone-somatostatin--from endocrinology to neurophysiology].Nihon Naibunpi Gakkai Zasshi. 1992 May 20;68(5):507-25. doi: 10.1507/endocrine1927.68.5_507. Nihon Naibunpi Gakkai Zasshi. 1992. PMID: 1353733 Review. Japanese.
-
Nutrient Sensing Overrides Somatostatin and Growth Hormone-Releasing Hormone to Control Pulsatile Growth Hormone Release.J Neuroendocrinol. 2015 Jul;27(7):577-87. doi: 10.1111/jne.12278. J Neuroendocrinol. 2015. PMID: 25808924 Review.
Cited by
-
Ultradian oscillations in somatostatin and growth hormone-releasing hormone mRNAs in the brains of adult male rats.Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):8920-4. doi: 10.1073/pnas.88.20.8920. Proc Natl Acad Sci U S A. 1991. PMID: 1681547 Free PMC article.
-
Somatostatin in the rat periventricular nucleus: sex differences and effect of gonadal steroids.Exp Brain Res. 2008 Jul;188(4):483-91. doi: 10.1007/s00221-008-1381-1. Epub 2008 Apr 18. Exp Brain Res. 2008. PMID: 18421448 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources